Isovue in Peripheral Digital Subtraction Angiography (DSA)

Summary

No significant differences is expected in observed motion artifacts, heat or pain reported during peripheral DSA performed for diagnostic and/or endovascular therapeutic purposes.

Timeline

Start

2010-04

Primary completion

2011-12

Completion

2011-12

Outcome

Missed primary endpoint

registry Isovue 250 VAS Score Immediately After Injection vs Visipaque 270 VAS Score Immediately After Injection; p = 0.3244; Mean Difference (Final Values) 0.5 NCT01075217 ↗

Drugs

Indications